Puylaert Kevin

Chief Sales Officer

Puylaert Kevin has filed 9 SEC Form 4 filings (14 transaction rows) across 1 company, with disclosures dating back to 2026. 9 of those filings fall inside the rolling window. Most recent filing: Oct 7, 2026.

On the most recent filing, Puylaert Kevin is listed as Chief Sales Officer at SOPHiA GENETICS SA. Inside the rolling window, Puylaert Kevin reported no open-market purchases and 7 open-market sales totaling $6K in SOPH. The largest disclosed transaction in the window is a sale of 624 SOPH shares on Apr 6, 2026, worth $3K.

Companies traded

Other insiders at SOPH

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$6K

reported sales (SEC code S)

Companies

1

in the rolling window

Source
SOPHSale$2KOct 7SEC ↗
SOPHSale$1KJul 7SEC ↗
SOPHSale$150May 20SEC ↗
SOPHSale$168Apr 21SEC ↗
SOPHSale$3KApr 8SEC ↗
SOPHSale$14Apr 1SEC ↗
SOPHSale$157Mar 20SEC ↗
Showing 1–7 of 7
1 / 1

Frequently asked questions

How many SEC Form 4 filings has Puylaert Kevin made?

Puylaert Kevin has filed 9 SEC Form 4 filings (14 transaction rows) across 1 company since 2026.

Which companies does Puylaert Kevin trade?

Puylaert Kevin has filed SEC Form 4 disclosures for 1 company, including SOPH.

When was Puylaert Kevin's most recent SEC Form 4 filing?

Puylaert Kevin's most recent SEC Form 4 filing on Tracefour is dated Oct 7, 2026.

What is Puylaert Kevin's job title?

On the most recent SEC Form 4 filings tracked by Tracefour, Puylaert Kevin is listed as Chief Sales Officer.

What is Puylaert Kevin's total buy and sell value in the current window?

Inside the rolling retention window, Puylaert Kevin bought $0 and sold $6K based on SEC Form 4 filings.

What was Puylaert Kevin's largest disclosed transaction?

The largest disclosed transaction in the current window is a sale of 624 SOPH shares on 2026-04-06, worth $3K, per SEC Form 4 filings.